Elevate Bio, LLC is Director of Allovir, Inc.. Currently has a direct ownership of 16.7 Million shares of ALVR, which is worth approximately $12.3 Million. The most recent transaction as insider was on Jul 28, 2022, when has been sold 3,253,796 shares (Common Stock) at a price of $4.61 per share, resulting in proceeds of $15,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.7M
0% 3M change
0% 12M change
Total Value Held $12.3 Million

ElevateBio, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 28 2022
BUY
Grant, award, or other acquisition
$15,000,000 $4.61 p/Share
3,253,796 Added 16.33%
16,674,766 Common Stock
EL

Elevate Bio, LLC

Director
Waltham, MA

Track Institutional and Insider Activities on ALVR

Follow Allovir, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALVR shares.

Notify only if

Insider Trading

Get notified when an Allovir, Inc. insider buys or sells ALVR shares.

Notify only if

News

Receive news related to Allovir, Inc.

Track Activities on ALVR